Last updated: October 18, 2023
Sponsor: Tanta University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Oral Facial Pain
Treatment
Spray-as-you-go
Nebulization
Clinical Study ID
NCT06088875
36264MS159/4/23
Ages 21-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age from 21to 65 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) physical status I or II and scheduled forelective surgery requiring general anesthesia , and known to have Temporomandibularjoint ankylosis and expected to be difficult intubation patient due to restriction ofjaw mobility and limited mouth opening less than 2 fingers.
Exclusion
Exclusion Criteria:
- History of allergy to dexmedetomidine or lidocaine.
- History of drug abuse.
- Concomitant use of medications which may exaggerate the heart rate (HR) response of -dexmedetomidine (e.g. digoxin or β-adrenergic antagonists), HR <50 beats/min,systolic blood pressure (SBP) <90 mmHg.
- Pregnancy.
- Morbid obesity( BMI more than 35).
- Patients on anticoagulants, nasal trauma, deformity or polyp, CSF rhinorrhea, fracturebase skull.
- Cardiac and/or respiratory disease, reactive airway disease, hepatic or renaldisorders.
Study Design
Total Participants: 50
Treatment Group(s): 2
Primary Treatment: Spray-as-you-go
Phase:
Study Start date:
October 18, 2023
Estimated Completion Date:
May 01, 2024
Study Description
Connect with a study center
Tanta University
Tanta, El-Gharbia 31527
EgyptActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.